Selank and Semax are both heptapeptides developed at the Russian Academy of Sciences, both administered intranasally, and both upregulate BDNF — yet they represent fundamentally different pharmacological approaches to brain function research. Understanding their differences is essential for choosing the right tool for specific research questions.
Different Origins, Different Profiles
| Feature | Selank | Semax |
|---|---|---|
| Parent molecule | Tuftsin (immunopeptide) | ACTH(4-10) (neurohormone) |
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Met-Glu-His-Phe-Pro-Gly-Pro |
| Primary effect | Anxiolytic | Neurotrophic/cognitive |
| Secondary effect | Cognitive enhancement | Neuroprotection |
| Key pathway | GABAergic + enkephalinergic | BDNF/TrkB + dopaminergic |
| Immune effects | Strong (tuftsin-derived) | Moderate |
| Hormonal effects | None | None (lacks ACTH 1-3) |
| Regulatory status | Approved in Russia (anxiolytic) | Approved in Russia (nootropic/stroke) |
Anxiety Research: Selank's Strength
For anxiolytic research, Selank is the clear choice. Its GABAergic modulation produces anxiolytic effects comparable to low-dose benzodiazepines without sedation or dependence. Semax has modest anxiolytic-like effects but this is not its primary pharmacological profile.
Cognitive Research: Semax's Strength
For pure cognitive enhancement research, Semax shows stronger effects across learning and memory paradigms. Its potent BDNF upregulation and direct neurotrophic activity make it a more targeted tool for studying memory consolidation, synaptic plasticity, and cognitive recovery.
Neuroprotection: Semax's Niche
Semax has extensive stroke and TBI research data that Selank lacks. For cerebrovascular research, ischemia-reperfusion models, or neurodegenerative paradigms, Semax's BDNF-mediated neuroprotective profile is more directly relevant.
Immune Research: Selank's Niche
Selank's tuftsin core gives it genuine immunomodulatory activity — IL-6 modulation, T-cell balance effects, and antiviral properties — that Semax does not share. For neuroimmunology research or studies at the CNS-immune interface, Selank provides a unique dual-action tool.
Both Available at Research Vials
Selank 11mg and Semax 10mg are both available in lyophilized form with full COA documentation.
References
- Seredenin SB, et al. Comparative study of Selank and Semax in anxiety and cognitive models. Bull Exp Biol Med. 2002;133(5):456-8. PMID: 12360348
- Dolotov OV, et al. Semax regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54-60. PMID: 16996072
Frequently Asked Questions
Research Use Only Disclaimer: All products referenced in this article are sold exclusively for laboratory research purposes. They are not intended for human or veterinary use, food additive use, drug use, or household use. This article is educational content based on published preclinical literature and does not constitute medical advice.
